Meet the Board of Advisers
Thrombosisadviser.com provides up-to-date information for physicians and patients on thromboembolic diseases.
It was developed in collaboration with a board of advisers, comprised of recognised experts in the field of thrombosis.
The Board of Advisers is dedicated to fostering awareness and understanding about new approaches in prevention, diagnosis, and treatment of thromboembolic diseases. It will provide ongoing support for the site.
Emeritus professor Sylvia Haas, MD
Sylvia Haas is Emeritus Professor of Medicine and had been Director of the Haemostasis and Thrombosis Research Group at the Institute for Experimental Oncology and Therapy Research, Technical University of Munich, Germany.
Her scientific focus is the development of new antithrombotic therapies, laboratory monitoring of anticoagulants, biomarkers, and tumour-associated thrombosis. Sylvia Haas is involved in several clinical trials — in particular, trials involving the prevention and treatment of arterial and venous thromboembolism.
She is a member of several international professional societies, including the International Society on Thrombosis and Haemostasis and the International Society of Angiology, and she is a fellow of the Southern African Society of Thrombosis and Haemostasis, the European Society for Surgical Research, and the German Societies of Surgery, Angiology, and Thrombosis and Haemostasis Research. She is also a member of the editorial board for several peer-reviewed journals, including Current Hematology Reports, International Journal of Angiology, and Clinical and Applied Thrombosis/Hemostasis.
Professor Gregory Y H Lip, MD
Gregory Lip is Professor of Cardiovascular Medicine at the University of Birmingham, UK, where he combines clinical work as a cardiologist with heading a large, multidisciplinary research group at the Centre for Cardiovascular Sciences. Professor Lip has a major research interest in the epidemiology and thromboembolic pathophysiology of atrial fibrillation. His research has led to improvements in clinical risk stratification, including development of the independently validated CHA2DS2-VASc and HAS-BLED scores that are now incorporated into international guidelines.
In 2014, Professor Lip was included in the Thomson Reuters ScienceWatch list of the World’s Most Influential Scientific Minds, and was ranked by Expertscape as one of the world's leading experts in the understanding and treatment of atrial fibrillation. He is a board member of the European Heart Rhythm Association (EHRA) and Chairman of its scientific documents committee, as well as being on the board of the European Society of Cardiology (ESC) Acute Cardiac Care Association.
Professor Lip has been involved in the development of international guidelines, including those from the American College of Chest Physicians (ACCP), the EHRA and the ESC, most recently the 2012 ESC Focused Update Guidelines on Atrial Fibrillation and Guidelines on Heart Failure. Professor Lip has acted as senior editor for major international textbooks and medical journals, the latter including Thrombosis and Haemostasis, Europace and Circulation.
Professor Alexander GG Turpie, MD
Alexander GG Turpie is an Emeritus Professor of Medicine at McMaster University, Hamilton, Ontario, Canada.
Professor Turpie’s research interests include new antithrombotic drugs for the management of venous and arterial thrombosis and anticoagulant therapy in patients with prosthetic heart valves. He has served on numerous professional and university-related committees and is a frequent lecturer at professional meetings worldwide.
He is the author of more than 700 published articles, abstracts, book chapters, and books, and a reviewer for many journals, including Annals of Internal Medicine, Circulation, The Lancet, and The New England Journal of Medicine. He also serves on the editorial boards of Vascular Medicine Review and HeartDrug.
Professor Turpie holds a medical degree from the University of Glasgow, Scotland. After completing residencies at the Royal Infirmary and Stobhill General Hospital, Glasgow, where he was also a clinical research fellow, he served as a clinic lecturer for the University of East Africa Medical School in Nairobi, Kenya. After returning to the University of Glasgow for additional training in haemostasis and thrombosis, he was appointed an MRC fellow at McMaster University, Hamilton, Canada, where he was also appointed to the full-time faculty in the Department of Medicine.
Professor the Lord Ajay K Kakkar, MBBS (Hons), BSc, PhD, FRCS, FRCP
Ajay Kakkar is a Professor of Surgery at University College London. He is also a Consultant Surgeon at University College London Hospital and Director of the Thrombosis Research Institute, London, UK.
Professor Kakkar is actively involved with several professional and academic committees, and is frequently invited to lecture at both national and international meetings. Professor Kakkar’s research interests are in the prevention and treatment of venous and arterial thromboembolic disease. He is involved in numerous international studies and registries investigating the prevention and management of venous thromboembolic disease, cancer-associated thrombosis and atrial fibrillation.